RESUMO
BACKGROUND: Scientific and professional development opportunities for early career scientists in low- and middle- income countries (LMICs) are limited and not consistent. There is a disproportionately low number of biomedical and clinical researchers in LMIC's relative to their high burden of disease, a disparity that is aggravated by emigration of up to 70% of scientists from their countries of birth for education and employment elsewhere. To help address this need, a novel University-accredited, immersive fellowship program was established by a large public-academic-private network. We sought to describe the program and summarize progress and lessons learned over its first 7-years. METHODS: Hallmarks of the program are a structured learning curriculum and bespoke research activities tailored to the needs of each fellow. Research projects expose the scientists to state-of-the-art methodologies and leading experts in their fields while also ensuring that learnings are implementable within their home infrastructure. Fellows run seminars on drug discovery and development that reinforce themes of scientific leadership and teamwork together with practical modules on addressing healthcare challenges within their local systems. Industry mentors achieve mutual learning to better understand healthcare needs in traditionally underserved settings. We evaluated the impact of the program through an online survey of participants and by assessing research output. RESULTS: More than 140 scientists and clinicians from 25 countries participated over the 7-year period. Evaluation revealed strong evidence of knowledge and skills transfer, and beneficial self-reported impact on fellow's research output and career trajectories. Examples of program impact included completion of post-graduate qualifications; establishment and implementation of good laboratory- and clinical- practice mechanisms; and becoming lead investigators in local programs. There was a high retention of fellows in their home countries (> 75%) and an enduring professional network among the fellows and their mentors. CONCLUSIONS: Our experience demonstrates an example for how multi-sectoral partners can contribute to scientific and professional development of researchers in LMICs and supports the idea that capacity-building efforts should be tailored to the specific needs of beneficiaries to be maximally effective. Lessons learned may be applied to the design and conduct of other programs to strengthen science ecosystems in LMICs.
Assuntos
Fortalecimento Institucional , Pesquisadores/educação , Currículo , Países em Desenvolvimento , Bolsas de Estudo , Feminino , Humanos , Liderança , Aprendizagem , Masculino , Mentores , Pesquisadores/provisão & distribuiçãoRESUMO
PURPOSE: To test the hypothesis that endothelin-1 is increased in giant cell arteritis. METHODS: Interventional case series. The medical history of four patients who presented to the University Eye Clinic Basel, Switzerland, with giant cell arteritis is reported. Endothelin-1 plasma levels were measured in all patients. The relevant medical literature was reviewed. RESULTS: All patients presented with typical histopathological signs of giant cell arteritis in the temporal artery biopsy. The erythrocyte sedimentation rate was increased in two patients. All patients showed significantly increased endothelin-1 plasma levels, ranging between 3.13 to 4.82 pg/ml (reference value for females: 1.42 pg/ml +/- 0.28 standard deviation, for males: 1.67 pg/ml +/- 0.34 standard deviation). CONCLUSION: The data obtained from the patients so far examined indicate that the level of circulating endothelin-1 is increased in giant cell arteritis. The clinical relevance of such an increase needs to be further evaluated.
Assuntos
Endotelina-1/sangue , Arterite de Células Gigantes/sangue , Idoso , Idoso de 80 Anos ou mais , Biópsia , Feminino , Arterite de Células Gigantes/diagnóstico , Humanos , Masculino , Artérias Temporais/patologiaRESUMO
In the autumn of 2006, the first cohort of students started with the bachelor programme in Basle. The whole curriculum had to be changed from the old system to the new two-cycle system. The implementation of the Bologna reform in Switzerland has been successful especially with regard to the very tight time schedule. Ongoing evaluation will detect fields for improvement which will of course arise in such a fundamental process of change. A major challenge for the future will be the sustainable consolidation of high quality in medical education.
Assuntos
Abscesso/diagnóstico , Doenças Palpebrais/diagnóstico , Doenças Musculares/diagnóstico , Músculos Oculomotores/patologia , Abscesso/tratamento farmacológico , Antibacterianos , Criança , Quimioterapia Combinada/uso terapêutico , Doenças Palpebrais/tratamento farmacológico , Feminino , Humanos , Imageamento por Ressonância Magnética , Doenças Musculares/tratamento farmacológico , Músculos Oculomotores/efeitos dos fármacosRESUMO
A 4-year-old boy presented with Goldenhar's syndrome, Duane's syndrome and bilateral papilledema. Magnetic resonance imaging of the brain was unremarkable. On lumbar puncture, the cerebrospinal fluid (CSF) pressure measured 36 cm H(2)O. CSF examination was normal. The diagnosis of pseudotumor cerebri was made, and treatment with acetazolamide was started. As the papilledema did not resolve, steroids were added to the treatment. Lumbar puncture was repeated after 1 month, and pressure was found to be 30 cm H(2)O. Because medical treatment was not effective in lowering the CSF pressure, optic nerve sheath fenestration was performed. Papilledema resolved over the next 2 months. To the best of our knowledge, this is the first case of Goldenhar's syndrome associated with pseudotumor cerebri.
Assuntos
Síndrome da Retração Ocular/complicações , Síndrome de Goldenhar/complicações , Pseudotumor Cerebral/complicações , Acetazolamida/uso terapêutico , Inibidores da Anidrase Carbônica/uso terapêutico , Pressão do Líquido Cefalorraquidiano , Pré-Escolar , Síndrome da Retração Ocular/patologia , Síndrome da Retração Ocular/terapia , Síndrome de Goldenhar/patologia , Síndrome de Goldenhar/terapia , Humanos , Imageamento por Ressonância Magnética , Masculino , Bainha de Mielina , Nervo Óptico/cirurgia , Papiledema/etiologia , Papiledema/terapia , Pseudotumor Cerebral/patologia , Pseudotumor Cerebral/terapiaRESUMO
PURPOSE: To analyze how far an ischemic component might have been involved in optic neuritis. CASE REPORT: a 32-year-old man with symptoms characteristic for optic neuritis underwent extensive clinical, laboratory/serological and vascular examination for systemic associations and vascular involvement. RESULTS: The patient was found to have a temporary ocular blood flow dysregulation and increased plasma endothelin-1 levels which decreased after the acute phase of the optic nerve. CONCLUSIONS: We conclude that there might be an ischemic component in this patient with optic neuritis and hypothesize that this ischemic component is at least in part due to a temporarily increased endothelin-1 level.
Assuntos
Endotelina-1/sangue , Neurite Óptica/sangue , Neurite Óptica/fisiopatologia , Artéria Retiniana/fisiopatologia , Adulto , Velocidade do Fluxo Sanguíneo , Humanos , Masculino , Fluxo Sanguíneo Regional/fisiologia , Acuidade Visual , Campos VisuaisRESUMO
In order to evaluate whether plasma levels of the potent vasoconstrictor endothelin-1 (ET-1) are increased in patients with multiple sclerosis (MS) and whether these patients exhibit an ET-1-mediated vascular dysregulation, ET-1 plasma levels were measured in 30 patients with MS. Blood flow velocities in the ophthalmic artery, central retinal artery, central retinal vein, short lateral posterior ciliary artery, and short medial posterior ciliary artery were assessed in parallel. ET-1 plasma levels were significantly increased in MS patients when compared to sex- and age-matched healthy controls (2.0 +/- 0.4 pg/ml, range 1.1-2.8 vs. 1.5 +/- 0.2 pg/ml, range 0.9-2.0; p < 0.001). Moreover, the patients exhibited significant alterations of extraocular blood flow. The role of ET-1 in the inflammatory process remains to be clarified.
Assuntos
Artérias Ciliares/fisiopatologia , Endotelina-1/sangue , Esclerose Múltipla/fisiopatologia , Artéria Oftálmica/fisiopatologia , Vasos Retinianos/fisiopatologia , Adulto , Velocidade do Fluxo Sanguíneo , Artérias Ciliares/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/diagnóstico por imagem , Artéria Oftálmica/diagnóstico por imagem , Fluxo Sanguíneo Regional , Artéria Retiniana/diagnóstico por imagem , Artéria Retiniana/fisiopatologia , Veia Retiniana/diagnóstico por imagem , Veia Retiniana/fisiopatologia , Vasos Retinianos/diagnóstico por imagem , Ultrassonografia Doppler em CoresRESUMO
BACKGROUND: Contradictory results on plasma endothelin-1 (ET-1) levels in patients with rheumatoid arthritis have been reported in previous studies. We therefore evaluated whether plasma ET-1 levels in patients with rheumatoid arthritis differ from those of normal controls. Since systemically increased levels of ET-1 are known to occur in tandem with primary or secondary vascular dysregulation, we also measured peripheral blood flow by means of nailfold capillaroscopy combined with a cold provocation test. MATERIAL/METHODS: We measured plasma levels of ET-1 in twelve patients with different stages of rheumatoid arthritis by means of a specific radioimmunoassay, and compared ET-1 values to those of healthy controls. Capillary blood flow and the frequency of cold-induced vasospasm were studied in parallel, using nailfold capillaroscopy combined with a cold provocation test. RESULTS: Plasma ET-1 levels were significantly increased in patients with rheumatoid arthritis (p = 0.01) when compared to controls (2.38+/-0.95 pg/ml vs. 1.53+/-0.38 pg/ml). Capillary blood flow was reduced when compared to our own normal values, and a cold-induced blood standstill was seen in 58% of the patients. CONCLUSIONS: Patients with rheumatoid arthritis exhibit significantly elevated levels of ET-1, which may be associated with the symptoms of vascular dysregulation observed in nailfold capillaroscopy. Even though the clinical conclusions should be drawn from this study with caution, additional therapy with calcium channel blockers or, possibly in the future, with ET-1 receptor blockers, may be beneficial in patients with rheumatoid arthritis.
Assuntos
Artrite Reumatoide/sangue , Endotelina-1/sangue , Adulto , Idoso , Artrite Reumatoide/patologia , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Angioscopia Microscópica , Pessoa de Meia-Idade , Radioimunoensaio , Fluxo Sanguíneo Regional , Fatores de TempoRESUMO
OBJECTIVE: visual disorders are among the earliest symptoms of Alzheimer's disease. It is, however, still controversial as to whether Alzheimer's disease impairs colour vision. In this study, colour vision of Alzheimer's disease patients was tested using the Ishihara test and the PV-16 choice test. The latter test, primarily designed for children, was chosen in order to avoid problems due to cognitive decline. METHODS: 26 patients with mild to severe Alzheimer's disease (M:F=5:21; mean age: 80+/-9 years, range: 53-95 years) and 25 controls (M:F=5:20; mean age 80+/-10 years, range: 56-100 years) were rated after undergoing complete neuro-ophthalmologic examination. RESULTS: the Alzheimer's disease patients made significantly more unspecific errors in the Ishihara test (P=0.02) and in the PV-16 choice test (P=0.0008) than the controls. No relation between test performance and severity of Alzheimer's disease was found. CONCLUSIONS: Alzheimer's disease patients have an unspecific colour vision deficiency independent of the severity of the disease.